Table 5 Progression criteria to a future confirmatory trial
| Â | Progression criteria | Achieved yes/no |
|---|---|---|
1. | Recruitment of 3 drug services | Yes |
2. | Recruitment of 2–3 pharmacies per clinic | Yes |
3. | 60 participants enrolled (20 from each clinic over 12 weeks) | No, only 10 participants enrolled |
4. | 50% target patients (presenting to participating drug services for a new episode of OST) eligible and consented | No, only 9% of target population were eligible and consented due to low numbers presenting for OST at all clinics and high numbers excluded due to receiving buprenorphine and not attending a participating pharmacy |
5. | > 95% consistency in recording of pharmacy attendance (comparing daily pharmacy dispensing records vs. patient self-login) | Yes, achieved 96% |
6. | Rates of follow-up at 12 weeks (> 70%) | Yes, achieved 90% (9/10) |
7. | Completion rates of economic data collection (> 70%) | Yes, achieved 100% |
8. | Missing (< 10% missing data per questionnaire) | Yes |